Nkarta (NKTX) Assets (2019 - 2026)
Nkarta's quarterly Assets came in at $372.1 million in Q1 2026, down 20.94% year-on-year from $470.6 million in Q1 2025, and down 7.95% quarter-over-quarter from $404.2 million in Q4 2025.
Nkarta has reported Assets for 8 years, with the latest figure at $372.1 million in Q1 2026.
- For the quarter ending Q1 2026, Assets fell 20.94% year-over-year to $372.1 million; the trailing twelve-month figure through Mar 2026 stood at $372.1 million (down 20.94% YoY), and the FY2025 full-year result was $404.2 million, down 19.35% from the prior year.
- Assets for Q1 2026 stood at $372.1 million, down from $404.2 million in the prior quarter.
- The five-year high for Assets was $576.9 million in Q1 2024, with the low at $306.3 million in Q1 2022.
- Average Assets over 5 years is $455.6 million, with a median of $458.2 million recorded in 2023.
- Year-over-year, Assets jumped 72.67% in 2022 and fell 20.94% in 2026.
- Tracing NKTX's Assets over 5 years: stood at $472.9 million in 2022, then declined by 19.89% to $378.9 million in 2023, then soared by 32.28% to $501.2 million in 2024, then decreased by 19.35% to $404.2 million in 2025, then dropped by 7.95% to $372.1 million in 2026.
- The last three Assets figures came in at $372.1 million (Q1 2026), $404.2 million (Q4 2025), and $427.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 14.93 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.37 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.73 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 78.88 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 33.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.48 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 23.64 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.87 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.13 Bn |
| 10 | Nkarta | 232.80 Mn | 232.80 Mn | - | 372.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 372.07 Mn |
| Dec 31, 2025 | 404.21 Mn |
| Sep 30, 2025 | 427.24 Mn |
| Jun 30, 2025 | 448.31 Mn |
| Mar 31, 2025 | 470.61 Mn |
| Dec 31, 2024 | 501.20 Mn |
| Sep 30, 2024 | 532.03 Mn |
| Jun 30, 2024 | 554.09 Mn |
| Mar 31, 2024 | 576.94 Mn |
| Dec 31, 2023 | 378.89 Mn |
| Sep 30, 2023 | 405.86 Mn |
| Jun 30, 2023 | 429.04 Mn |
| Mar 31, 2023 | 458.17 Mn |
| Dec 31, 2022 | 472.94 Mn |
| Sep 30, 2022 | 503.80 Mn |
| Jun 30, 2022 | 503.64 Mn |
| Mar 31, 2022 | 306.30 Mn |
| Dec 31, 2021 | 273.90 Mn |
| Sep 30, 2021 | 292.47 Mn |
| Jun 30, 2021 | 309.11 Mn |
| Mar 31, 2021 | 325.69 Mn |
| Dec 31, 2020 | 337.65 Mn |
| Sep 30, 2020 | 352.30 Mn |
| Jun 30, 2020 | 43.62 Mn |
| Dec 31, 2019 | 48.41 Mn |